Dr Reddys Laboratories Ltd Share Price Today - Live Blog for March 30, 2026

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -2.04% in its share price, and it currently trades at 1255.60 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd experienced a -1.54% dip in its share price and is currently trading at 1261.90. The stock has a PE ratio of 19.3700, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd is facing a -1.54% decline and is currently trading at 1261.90 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd experienced a -1.60% downturn in its share price, and it's currently trading at 1261.20. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd observed a -1.60% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1261.20. The stock has a PE ratio of 19.3700, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd is facing a -0.87% decline and is currently trading at 1270.60 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

With a -0.87% decrease, Dr Reddys Laboratories Ltd's share price is currently at 1270.60. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.3700, while the industry PE is 31.9340.

Dr Reddys Laboratories Ltd witnessed a -1.73% decrease in its share price, and it is currently trading at 1259.50. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.3700, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd witnessed a -1.73% decrease in its share price, and it is currently trading at 1259.50. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.3700, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -1.66% in its share price, and it currently trades at 1260.40 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has dropped by -1.66%, a development that warrants careful analysis. Presently trading at 1260.40, investors are assessing whether this presents an opportunity or a risk.